Balchem Corp
BCPC156.300USD
-2.420-1.52%
종가 12/19, 16:00（ET）시세는 15분 지연됩니다
5.06B시가총액
33.90P/E TTM
자세한 내용은 Balchem Corp 회사
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Balchem Corp 정보
종목 코드 BCPC
회사 이름Balchem Corp
상장일Jun 03, 1986
CEOHarris (Theodore L)
직원 수1361
유형Ordinary Share
회계 연도 종료Jun 03
주소- -
도시- -
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가- -
우편 번호- -
전화- -
웹사이트- -
종목 코드 BCPC
상장일Jun 03, 1986
CEOHarris (Theodore L)
Balchem Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
--
-100.00%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
--
-100.00%
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. Martin L. Reid
Mr. Martin L. Reid
Senior Vice President and Chief Supply Chain Officer
Senior Vice President and Chief Supply Chain Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
지역별USD
이름
수익
비율
United States
186.71M
73.08%
Foreign Countries
68.76M
26.92%
사업별
지역별
사업별USD
이름
수익
비율
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
주식 보유 통계
마지막 업데이트: Wed, Oct 8
마지막 업데이트: Wed, Oct 8
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
기타
63.60%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
기타
63.60%
주주 유형
주주
비율
Investment Advisor
51.15%
Investment Advisor/Hedge Fund
28.69%
Hedge Fund
6.00%
Pension Fund
2.43%
Research Firm
1.95%
Sovereign Wealth Fund
1.59%
Bank and Trust
1.04%
Individual Investor
0.54%
Family Office
0.06%
기타
6.56%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
692
30.08M
92.73%
+17.89K
2025Q3
707
30.06M
92.66%
+267.74K
2025Q2
685
29.78M
92.71%
+58.29K
2025Q1
661
29.74M
93.11%
-556.18K
2024Q4
638
29.76M
94.56%
+6.32K
2024Q3
611
29.83M
94.33%
+196.23K
2024Q2
600
29.66M
94.99%
-187.86K
2024Q1
588
29.84M
94.20%
-559.06K
2023Q4
578
29.57M
93.53%
+265.95K
2023Q3
565
29.33M
93.21%
-102.61K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
4.44M
13.67%
-111.30K
-2.45%
Jun 30, 2025
The Vanguard Group, Inc.
3.89M
11.99%
+47.60K
+1.24%
Jun 30, 2025
Conestoga Capital Advisors, LLC
1.15M
3.54%
-19.03K
-1.63%
Jun 30, 2025
State Street Investment Management (US)
1.23M
3.78%
-1.53K
-0.12%
Jun 30, 2025
Wasatch Global Investors Inc
960.09K
2.96%
-108.92K
-10.19%
Jun 30, 2025
Geode Capital Management, L.L.C.
980.97K
3.02%
+14.33K
+1.48%
Jun 30, 2025
Geneva Capital Management LLC
895.53K
2.76%
+64.72K
+7.79%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
575.40K
1.77%
-18.35K
-3.09%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
469.08K
1.45%
+38.60K
+8.97%
Jun 30, 2025
JP Morgan Asset Management
389.05K
1.2%
-7.19K
-1.82%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Invesco S&P SmallCap Materials ETF
6.89%
Invesco S&P SmallCap Quality ETF
1.2%
First Trust Horizon Managed Vol Small/Mid ETF
1.05%
ProShares Russell 2000 Dividend Growers ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.64%
iShares S&P Small-Cap 600 Growth ETF
0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.57%
Parametric Equity Premium Income ETF
0.56%
더 보기
Invesco S&P SmallCap Materials ETF
비율6.89%
Invesco S&P SmallCap Quality ETF
비율1.2%
First Trust Horizon Managed Vol Small/Mid ETF
비율1.05%
ProShares Russell 2000 Dividend Growers ETF
비율0.91%
Invesco S&P SmallCap Low Volatility ETF
비율0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
비율0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
비율0.64%
iShares S&P Small-Cap 600 Growth ETF
비율0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
비율0.57%
Parametric Equity Premium Income ETF
비율0.56%
주식 배당금
지난 5년 동안 총
104.59M
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Dec 10, 2025
BCPC.NB Final Cash Dividend of gross USD 0.96 paid on Jan 20, 2026 going ex on Dec 23, 2025
Dec 23, 2025
Jan 20, 2026
Dec 23, 2025
Dec 10, 2024
BCPC.NB Final Cash Dividend of gross USD 0.87 paid on Jan 17, 2025 going ex on Dec 26, 2024
Dec 26, 2024
Jan 17, 2025
Dec 26, 2024
Dec 05, 2023
BCPC.NB Final Cash Dividend of gross USD 0.79 paid on Jan 19, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 19, 2024
Dec 26, 2023
Dec 06, 2022
BCPC.NB Final Cash Dividend of gross USD 0.71 paid on Jan 20, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 20, 2023
Dec 23, 2022
Dec 16, 2021
BCPC.NB Final Cash Dividend of gross USD 0.64 paid on Jan 21, 2022 going ex on Dec 27, 2021
Dec 28, 2021
Jan 21, 2022
Dec 27, 2021
Dec 17, 2020
BCPC.NB Final Cash Dividend of gross USD 0.58 paid on Jan 22, 2021 going ex on Dec 24, 2020
Dec 28, 2020
Jan 22, 2021
Dec 24, 2020
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
자주 묻는 질문
Balchem Corp의 상위 5대 주주는 누구인가요?
Balchem Corp의 상위 5대 주주는 다음과 같습니다:
BlackRock Institutional Trust Company, N.A.는 4.44M주의 주식을 보유하고 있으며, 전체 주식의 13.67%를 차지합니다.
The Vanguard Group, Inc.는 3.89M주의 주식을 보유하고 있으며, 전체 주식의 11.99%를 차지합니다.
Conestoga Capital Advisors, LLC는 1.15M주의 주식을 보유하고 있으며, 전체 주식의 3.54%를 차지합니다.
State Street Investment Management (US)는 1.23M주의 주식을 보유하고 있으며, 전체 주식의 3.78%를 차지합니다.
Wasatch Global Investors Inc는 960.09K주의 주식을 보유하고 있으며, 전체 주식의 2.96%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 4.44M주의 주식을 보유하고 있으며, 전체 주식의 13.67%를 차지합니다.
The Vanguard Group, Inc.는 3.89M주의 주식을 보유하고 있으며, 전체 주식의 11.99%를 차지합니다.
Conestoga Capital Advisors, LLC는 1.15M주의 주식을 보유하고 있으며, 전체 주식의 3.54%를 차지합니다.
State Street Investment Management (US)는 1.23M주의 주식을 보유하고 있으며, 전체 주식의 3.78%를 차지합니다.
Wasatch Global Investors Inc는 960.09K주의 주식을 보유하고 있으며, 전체 주식의 2.96%를 차지합니다.
Balchem Corp의 상위 3대 주주 유형은 무엇인가요?
Balchem Corp의 주요 주주 유형 상위 3가지는
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC입니다.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC입니다.
Balchem Corp(BCPC)의 주식을 보유한 기관은 몇 개입니까?
2025Q4 기준으로, Balchem Corp의 주식을 보유한 기관은 총 692곳이며, 이들이 보유한 주식의 총 가치는 약 30.08M로 전체 발행 주식의 92.73%를 차지합니다. 이는 2025Q3 대비 0.07% 증가한 수치입니다.
Balchem Corp의 최대 수익원은 무엇인가요?
FY2025Q2 기준, Balchem Corp의 Product Sales Revenue 부문이 가장 높은 매출을 기록했으며, 금액은 255.04M로 전체 매출의 99.83%를 차지했습니다.
